−0.015AUD
−3.08 MAUD
7.24 MAUD
173.03 M
About BIOME AUSTRALIA LIMITED
Sector
CEO
Blair William Brabin Vega Norfolk
Headquarters
Collingwood
Website
Founded
2018
ISIN
AU0000184137
FIGI
BBG0136NNN81
Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and complementary medicines under the Activated Probiotic brand. The company was founded by Blair Vega Norfolk on July 6, 2018 and is headquartered in Collingwood, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIO is 0.40 AUD — it has decreased by 1.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BIOME AUSTRALIA LIMITED stocks are traded under the ticker BIO.
BIOME AUSTRALIA LIMITED is going to release the next earnings report on Jul 23, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOME AUSTRALIA LIMITED revenue for the last quarter amounts to 1.80 M AUD despite the estimated figure of 1.81 M AUD. In the next quarter revenue is expected to reach 1.39 M AUD.
Yes, you can track BIOME AUSTRALIA LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOME AUSTRALIA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOME AUSTRALIA LIMITED EBITDA is −3.04 M AUD, and current EBITDA margin is −42.26%. See more stats in BIOME AUSTRALIA LIMITED financial statements.